Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateSector Deep DivesUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Pharma - Formulators
  4. /Lupin Ltd
MomentumDeep Value

Lupin Ltd: Stock Analysis & Fundamentals

Updated this week

Lupin Ltd (Pharma - Formulators) — fundamental analysis, earnings data, and key metrics. PE: 18.6. ROE: 29.1%. This stock is not currently in the Nifty 500 momentum outperformers list.

Lupin Ltd Key Facts

What's Happening

🌐FII stake decreased 1.0% this quarter
🏛️DII accumulation — stake up 1.5%

Key Numbers

Current Price
₹2,344
Dividend Yield
0.51%
Market Cap
1.1L Cr
Valuation
N/A

Other Top Pharma - Formulators Stocks Beating Nifty 500

Cipla Ltd
Weak
+8.1%
Zydus Lifesciences Ltd
Strong • 6w streak
+14.3%
Mankind Pharma Ltd
Average
+14.0%
Aurobindo Pharma Ltd
Average • 12w streak
+11.3%
Emcure Pharmaceuticals Ltd
Average • 12w streak
+10.4%
← Back to Pharma - FormulatorsDashboard

Frequently Asked Questions: Lupin Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Lupin Ltd's latest quarterly results?

Lupin Ltd's latest quarterly results (Mar 2026) show

  • PAT Growth YoY: +87.9%
  • Revenue Growth YoY: +31.9%
  • Operating Margin: 33.0%

What is Lupin Ltd's current PE ratio?

Lupin Ltd's current PE ratio is 18.6x.

  • Current PE: 18.6x
  • Market Cap: 1.1 Lakh Cr
  • Dividend Yield: 0.51%

What is Lupin Ltd's price-to-book ratio?

Lupin Ltd's price-to-book ratio is 4.8x.

  • Price-to-Book (P/B): 4.8x
  • Book Value per Share: ₹491
  • Current Price: ₹2344

Is Lupin Ltd a fundamentally strong company?

Lupin Ltd's fundamental strength based on key financial ratios

  • Return on Capital (ROCE): 30.0%

Is Lupin Ltd debt free?

Lupin Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹7,000 Cr

What is Lupin Ltd's return on equity (ROE) and ROCE?

Lupin Ltd's return ratios over recent years

  • FY2024: ROCE 16.0%
  • FY2025: ROCE 21.0%
  • FY2026: ROCE 30.0%

Is Lupin Ltd's cash flow positive?

Lupin Ltd's operating cash flow is positive (FY2026).

  • Cash from Operations (CFO): ₹7,000 Cr
  • Free Cash Flow (FCF): ₹3,000 Cr
  • CFO/PAT Ratio: 137% (strong cash conversion)

What is Lupin Ltd's dividend yield?

Lupin Ltd's current dividend yield is 0.51%.

  • Dividend Yield: 0.51%
  • Current Price: ₹2344

Who holds Lupin Ltd shares — promoters, FII, DII?

Lupin Ltd's shareholding pattern (Mar 2026)

  • Promoters: 46.9%
  • FII (Foreign): 21.7%
  • DII (Domestic): 25.3%
  • Public: 6.1%

Is promoter holding increasing or decreasing in Lupin Ltd?

Lupin Ltd's promoter holding has decreased recently.

  • Current Promoter Holding: 46.9% (Mar 2026)
  • Previous Quarter: 46.9% (Dec 2025)
  • Change: -0.04% (decreasing — worth monitoring)

Is Lupin Ltd a new momentum entry or an established outperformer?

Lupin Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Lupin Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Lupin Ltd may be worth studying

  • Cash flow is positive — CFO ₹7,000 Cr

What is the investment thesis for Lupin Ltd?

Lupin Ltd investment thesis summary:

What is the future outlook for Lupin Ltd?

Lupin Ltd's forward outlook based on current data signals

  • Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.